Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenmetrazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 known ✓ | P23975 | 5/20 | 0.96 |
| ▸ | SLC6A3 known ✓ | Q01959 | 5/20 | 0.96 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.96 |
| ▸ | HTR2B | P41595 | 1/20 | 0.96 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.70 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TACR1 | P25103 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenmetrazine SCHEMBL33984 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159761 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL8094204 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15159760 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL15154744 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL265002 | 0.98 | SLC6A2 (1.00) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL22462307 | 0.96 | SLC6A2 (0.96) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL3341647 | 0.89 | SLC6A2 (0.81) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| SCHEMBL1666720 | 0.87 | SLC6A2 (0.80) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 | |
| Phenmetrazine SCHEMBL28570473 | 0.85 | SLC6A2 (0.74) | SLC6A2SLC6A3ADRA1AHTR2BCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3902 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220170019-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | UNIVERSIDAD DE MÁLAGA (ES) | 2022-06-02 | — | — | US | claimed |
| EP-3960859-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | Servicio Andaluz De Salud (ES) | 2022-03-02 | — | — | EP | claimed |
| CN-114053206-A | Medicinal floating preparation and preparation method thereof | 常州恒邦药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-114053207-A | Sustained-release pharmaceutical composition and preparation method thereof | 常州恒邦药业有限公司 | 2022-02-18 | — | — | CN | claimed |
| US-20220008334-A1 | GASTRIC RETENTIVE DEVICES | CLEXIO BIOSCIENCES LTD. (IL) | 2022-01-13 | — | — | US | claimed |
| US-11147766-B2 | Gastric retentive devices | CLEXIO BIOSCIENCES LTD. (IL) | 2021-10-19 | — | — | US | claimed |
| WO-2020165482-A1 | NANOSYSTEM BASED ON MICRORNA FOR TREATING OBSESITY | SERVICIO ANDALUZ DE SALUD (ES) | 2020-08-20 | — | — | WO | claimed |
| US-9649093-B2 | Cavity-filling biopsy site markers | SENORX, INC. (US) | 2017-05-16 | — | — | US | claimed |
| US-20160120510-A1 | CAVITY-FILLING BIOPSY SITE MARKERS | SENORX, INC. | 2016-05-05 | — | — | US | claimed |
| US-8679535-B2 | Sustained release matrix systems for highly soluble drugs | ENDO PHARMACEUTICALS INC. (US) | 2014-03-25 | — | — | US | claimed |
| WO-2003089012-A2 | CAVITY FILLING BIOPSY SITE MARKER | SENORX, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| US-20020188196-A1 | Cavity-filling biopsy site markers | SENORX, INC. | 2002-12-12 | — | — | US | claimed |
| US-20020044968-A1 | High amount of plasticizer to facilitate plasticization of the matrix material at low shear and then reduced prior to adding the encapsulant to reduce post extrusion | GENERAL MILLS, INC. | 2002-04-18 | — | — | US | claimed |
| JP-2002511777-A | — | — | 2002-04-16 | — | — | JP | claimed |
| EP-1119345-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2001-08-01 | — | — | EP | claimed |
| WO-2000021504-A1 | ENCAPSULATION OF SENSITIVE LIQUID COMPONENTS INTO A MATRIX TO OBTAIN DISCRETE SHELF-STABLE PARTICLES | GENERAL MILLS, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| EP-0935523-A4 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GEN MILLS INC (US) | 1999-12-29 | — | — | EP | claimed |
| EP-0935523-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | GENERAL MILLS, INC. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998018610-A1 | EMBEDDING AND ENCAPSULATION OF CONTROLLED RELEASE PARTICLES | LENGERICH BERNHARD H VAN (US) | 1998-05-07 | — | — | WO | claimed |
| US-5023088-A | Drug delivery dispenser | ALZA CORPORATION (US) | 1991-06-11 | — | — | US | claimed |